Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.

Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, Shahri N, Berg PH; MBDL and MBCU Study Groups.

Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1750-7. doi: 10.1167/iovs.12-11055.

PMID:
23404115
2.

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.

Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G; ROADMAP Trial Investigators.

N Engl J Med. 2011 Mar 10;364(10):907-17. doi: 10.1056/NEJMoa1007994.

3.

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes.

Scott R, Loeys T, Davies MJ, Engel SS; Sitagliptin Study 801 Group.

Diabetes Obes Metab. 2008 Sep;10(10):959-69. doi: 10.1111/j.1463-1326.2007.00839.x. Epub 2008 Jan 14.

PMID:
18201203
4.

Prevalence of obesity in Poland.

Milewicz A, Jedrzejuk D, Lwow F, Białynicka AS, Lopatynski J, Mardarowicz G, Zahorska-Markiewicz B.

Obes Rev. 2005 May;6(2):113-4. Review.

PMID:
15836460
5.

Cardiovascular risk factors in the Lublin Region population with and without type-2 diabetes mellitus.

Mardarowicz G, Lopatyński J, Szcześniak G.

Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):471-7.

PMID:
15323239
6.

Diabetes mellitus type-2 is unknown in 75% of cases--results of a population study in rural areas of the Lublin Region (Eastern Poland).

Mardarowicz G, Lopatyński J, Szcześniak G, Król H.

Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):466-70.

PMID:
15323238
7.

Clinically evident thyroid gland disorders in Lublin Region.

Mardarowicz G, Lopatyński J, Szydłowski W.

Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):462-5.

PMID:
15323237
8.

Metabolic syndrome.

Mardarowicz G, Lopatyński J, Nicer T.

Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):426-31. Review.

PMID:
15315027
9.

Usefulness of glucose levels determination with glucometer in epidemiologic research.

Nicer T, Mardarowicz G, Łopatyński J.

Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):420-5.

PMID:
15315026
11.

Primary and specialist diabetes care three years after introduction of health care system reform in Poland.

Mardarowicz G, Łopatyński J.

Ann Univ Mariae Curie Sklodowska Med. 2002;57(1):550-5.

PMID:
12898974
12.

[The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)].

Łopatyński J, Mardarowicz G, Nicer T, Szcześniak G, Król H, Matej A, Szydłowski W, Paszkowski J, Dabek K, Zmurowska B, Szyprowska-Grzegorczyk E.

Pol Arch Med Wewn. 2001 Sep;106(3):781-6. Polish.

PMID:
11928586
13.

[Unfavorable blood lipid indicators in obesity].

Hanzlik J, Sodolski W, Barud W, Ostrowski S, Mosiewicz J, Mardarowicz G.

Kardiol Pol. 1992;36(1):13-7. Polish.

PMID:
1583818
14.

[Content of overall fat in the body and levels of selected coronary risk factors].

Sodolski W, Hanzlik J, Barud W, Ostrowski S, Mardarowicz G, Klimaczak W.

Kardiol Pol. 1989;32(1):7-12. Polish.

PMID:
2811023
15.

[Prevalence of coronary disease risk factors in the male population 40-59 years of age from the housing complex "Czechów" in Lublin].

Hanzlik J, Tomaszewski J, Sodolski W, Barud W, Krawczyk A, Mardarowicz G, Klimczak W, Ostrowski S, Koprianiuk E.

Kardiol Pol. 1989;32 Suppl 1:71-8. Polish.

PMID:
2638436
16.

[A case of multiglandular hormonal deficiency type I].

Grzywa M, Mardarowicz G.

Pol Tyg Lek. 1988 Sep 26;43(39):1260-2. Polish. No abstract available.

PMID:
3244585
17.

[Use of beta-adrenolytics in the treatment of thyrotoxicosis].

Mardarowicz G, Lopatyński J.

Pol Tyg Lek. 1987 Sep 7;42(36):1099-103. Polish. No abstract available.

PMID:
2892187
18.

[Pancreatic glucagon of blood plasma in Graves-Basedow disease in different stages of thyroid activity].

Lopatyński J, Tomaszewski J, Hanzlik J, Mardarowicz G.

Pol Arch Med Wewn. 1985 Mar;73(3):160-8. Polish. No abstract available.

PMID:
3840254
19.

[Glucose tolerance and insulin secretion in patients with thyrotoxicosis treated with propranolol].

Lopatyński J, Mardarowicz G, Tomaszewski J.

Przegl Lek. 1984;41(5):365-9. Polish. No abstract available.

PMID:
6382446
20.

[Cholesterol in serum lipoprotein fractions in patients with hyperthyroidism treated with propranolol].

Lopatyński J, Mardarowicz G, Kozak J, Klimczak W.

Pol Arch Med Wewn. 1983 Oct;70(4):149-59. Polish. No abstract available.

PMID:
6582446
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk